A provider of supplemental health and life insurance that fills the gaps in regular coverage, selling cancer, medical, accident, and disability policies to workers at their jobsites in the U.S. and Japan. Begun in 1955 in Columbus, Georgia, when the three Amos brothers sold insurance door-to-door, it took its name from the American Family Life Assurance Company. Its quacking duck mascot came about after ad-agency creatives in Central Park noticed the name "Aflac" sounds like a duck.
Aflac Japan discloses unauthorized third-party access to its systems between June 15-25, 2026.
The incident affected certain Aflac Japan systems, and the company suspended some systems to contain the breach while continuing to serve policyholders.
Show detailsHide details
Aflac Life Insurance Japan Ltd., a wholly owned subsidiary of Aflac Incorporated, discovered the unauthorized access on June 25, 2026.
Impacted files may contain policy and coverage details, personal information, and bank account information.
Aflac Japan has notified the Japan Financial Services Agency and other authorities and plans to notify affected individuals.
The incident is limited to Japan; U.S. business systems were not accessed, and the full scope and impact are not yet known.
Aflac issues ¥65.9B in four tranches of senior notes due 2029-2036
The notes were offered under Aflac's existing shelf registration statement (File No. 333-281977) and a prospectus supplement dated May 21, 2026.
Show detailsHide details
On May 28, 2026, Aflac Incorporated issued ¥3.1B of 2.117% Senior Notes due 2029, ¥41.8B of 2.802% Senior Notes due 2031, ¥13.1B of 3.123% Senior Notes due 2033, and ¥7.9B of 3.482% Senior Notes due 2036.
Net proceeds from the offering will be used for general corporate purposes.
The notes are unsecured and rank equally with Aflac's other unsecured senior indebtedness; they were issued under the base indenture and four supplemental indentures with The Bank of New York Mellon Trust Company, N.A. as trustee.
The underwriting agreement, dated May 21, 2026, was led by representatives Mizuho Securities USA LLC, SMBC Nikko Securities America, Inc., Morgan Stanley & Co. International plc, and MUFG Securities EMEA plc.
8.01 Other Events · 9.01 Financial Statements and Exhibits
Aflac issued $500M of 5.150% Senior Notes due 2036 in a public offering.
The Notes were sold under an underwriting agreement dated May 11, 2026, with representatives Goldman Sachs & Co. LLC, Mizuho Securities USA LLC, SMBC Nikko Securities America, Inc., and Wells Fargo Securities, LLC.
Show detailsHide details
On May 14, 2026, Aflac Incorporated issued $500,000,000 aggregate principal amount of 5.150% Senior Notes due 2036.
Interest on the Notes is payable semi-annually on May 14 and November 14, beginning November 14, 2026, at a rate of 5.150% per annum.
The Company may redeem the Notes at its option prior to February 14, 2036 (Par Call Date) at a make-whole redemption price, and at par plus accrued interest on or after that date.
Net proceeds are intended for general corporate purposes; the Notes are unsecured senior obligations ranking equally with existing and future unsecured senior indebtedness.
8.01 Other Events · 9.01 Financial Statements and Exhibits
Aflac reports Q3 2025 net earnings of $1.6 billion, or $3.08 per diluted share.
Total revenues were $4.7 billion in Q3 2025, up from $2.9 billion in Q3 2024, driven by net investment gains of $275 million versus losses of $1.4 billion a year ago.
Show detailsHide details
Adjusted earnings were $1.3 billion, up 9.6% year-over-year; adjusted earnings per diluted share rose 15.3% to $2.49.
Aflac Japan's pretax adjusted profit margin improved to 52.2% from 44.7%, with sales up 11.8% to ¥19.6 billion.
Aflac U.S. net earned premiums increased 2.5% to $1.5 billion, with pretax adjusted earnings up 7.1% to $375 million.
The board declared a fourth quarter dividend of $0.58 per share, payable December 1, 2025; the company repurchased $1.0 billion of shares in Q3.
2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits